JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NARAHASHI, T.
Right arrow Articles by FRAZIER, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NARAHASHI, T.
Right arrow Articles by FRAZIER, D. T.
Journal of Pharmacology And Experimental Therapeutics, Vol. 169, Issue 2, 224-228, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


DEPENDENCE OF TETRODOTOXIN BLOCKAGE OF NERVE MEMBRANE CONDUCTANCE ON EXTERNAL pH

TOSHIO NARAHASHI 1, JOHN W. MOORE 1, and DONALD T. FRAZIER 1

1 Department of Physiology and Pharmacology, Duke University Medical Center, Durham, North Carolina and the Department of Physiology, University of New Mexico School of Medicine, Albuquerque, New Mexico

The effectiveness of tetrodotoxin in blocking the peak transient sodium conductance of squid giant axons has been compared at pH 7 and pH 9 under voltage clamp conditions. Tetrodotoxin was much more potent at pH 7 than at pH 9, and the result is compatible with the concept that the cation forms of tetrodotoxin are mainly responsible for the blocking action.

Submitted on March 7, 1969
Accepted on June 19, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.